Target intelligence / Profile preview

β-barrel assembly machine subunit A (BamA)

Target
BamA
Molecular classification
Outer membrane protein assembly factor, Integral membrane protein, Protein translocation/assembly factor, Omp85 superfamily, Multisubunit protein complex subunit (part of β-barrel assembly machine/BAM complex)
01

Overview

β-barrel assembly machine subunit A (BamA) is an integral outer membrane protein found in all Gram-negative bacteria and is essential for bacterial survival. BamA forms the central component of the β-barrel assembly machine (BAM) complex, a multi-protein system (BamA-E) that catalyzes the folding and insertion of outer membrane β-barrel proteins, crucial for cell envelope integrity. BamA is itself a β-barrel protein and acts as a scaffold and chaperone, recognizing and assisting in the proper folding and membrane integration of diverse β-barrel substrates via its periplasmic POTRA domains and C-terminal β-barrel domain. BamA's activity is vital for biogenesis of the bacterial outer membrane, making it a promising target for novel antibiotics aimed at disabling Gram-negative pathogens by compromising their outer membrane integrity. No clinically approved drugs target BamA yet, but it is under active investigation as an antibacterial target.

Other names
Omp85Outer membrane protein assembly factor BamAOmp85 family proteinOuter membrane protein 85
02

Mechanism of action

Inhibition of BamA prevents the assembly and integration of β-barrel proteins into the bacterial outer membrane, leading to defective outer membranes and bacterial death

03

Biological functions

Outer membrane protein foldingOuter membrane protein assembly/integrationCell envelope biogenesisProtein translocationMembrane chaperoning activity (catalyzing β-barrel folding)
04

Disease associations

Infection (essential for Gram-negative bacterial viability, thus a potential antibiotic target)Not directly associated with human pathology, but critical to bacterial survival
05

Safety considerations

Targeting BamA may affect commensal Gram-negative bacteria and could drive resistanceOff-target toxicity in mitochondria or chloroplasts is not reported, but should be monitored in drug development due to evolutionary conservation of the Omp85 superfamily
06

Interacting drugs

None currently approved; experimental inhibitors targeting BamA or BAM complex are under investigation as antibacterial agents
07

Biomarkers

None in clinical use; presence/level of BamA may serve as marker of Gram-negative bacterial organisms in research settings

Beyond the preview

Go deeper on β-barrel assembly machine subunit A (BamA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on β-barrel assembly machine subunit A (BamA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call